GetTopicDetailResponse(id=61a0e4856c, topicName=FL, introduction=FL, content=null, image=null, comments=1, allHits=702, url=https://h5.medsci.cn/topic?id=7485, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=96972, tagList=[TagDto(tagId=96972, tagName=FL)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2277250, encodeId=052122e725066, content=<a href='/topic/show?id=61a0e4856c' target=_blank style='color:#2F92EE;'>#FL#</a>濾泡性淋巴瘤（FL）約占非霍奇金淋巴瘤的三分之一, objectTitle=通過全基因組測序揭示濾泡淋巴瘤三種亞型，具有不同的起源細(xì)胞和患者結(jié)局, objectType=article, longId=891424, objectId=7b3289142412, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220726/1658822648203_5552845.jpg, objectUrl=/article/show_article.do?id=7b3289142412, replyNumber=0, likeNumber=6, createdTime=2025-08-14, rootId=0, userName=ms4000001513304915, userId=a1646442901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=廣東省, moduleDTOList=[ModuleDTO(moduleId=7b3289142412, moduleTitle=通過全基因組測序揭示濾泡淋巴瘤三種亞型，具有不同的起源細(xì)胞和患者結(jié)局, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7b3289142412)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2259420, encodeId=10f22259420d2, content=<a href='/topic/show?id=5bd36658e94' target=_blank style='color:#2F92EE;'>#濾泡性淋巴瘤#</a> <a href='/topic/show?id=61a0e4856c' target=_blank style='color:#2F92EE;'>#FL#</a>, objectTitle=濾泡性淋巴瘤一線和二線治療的緩解持續(xù)時間都是生存的強預(yù)測因素, objectType=article, longId=870747, objectId=95698e0747ce, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240509/1715265959081_5579292.png, objectUrl=/article/show_article.do?id=95698e0747ce, replyNumber=0, likeNumber=31, createdTime=2025-04-07, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95698e0747ce, moduleTitle=濾泡性淋巴瘤一線和二線治療的緩解持續(xù)時間都是生存的強預(yù)測因素, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=95698e0747ce)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2228541, encodeId=3c74222854154, content=<a href='/topic/show?id=5bd36658e94' target=_blank style='color:#2F92EE;'>#濾泡性淋巴瘤#</a> <a href='/topic/show?id=61a0e4856c' target=_blank style='color:#2F92EE;'>#FL#</a>, objectTitle=【BJH】中國多中心研究證實對于觀察等待的FL患者，至淋巴瘤治療時間影響預(yù)后, objectType=article, longId=845234, objectId=2eb684523454, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240925/1727246740477_8538692.png, objectUrl=/article/show_article.do?id=2eb684523454, replyNumber=0, likeNumber=155, createdTime=2024-09-30, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2eb684523454, moduleTitle=【BJH】中國多中心研究證實對于觀察等待的FL患者，至淋巴瘤治療時間影響預(yù)后, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2eb684523454)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
